Aspen/MSD NL 8 B.V.
Transaction details
The acquisition of MSD NL 8 B.V. (a subsidiary of Merck & Co Incorporated) by Aspen Pharmacare Holdings Limited has been cleared by the Competition Authority.
Case details
- Notification date:17 July 2013
- Publication date:17 July 2013
- Economic sector:Manufacturing - C
- Economic sub-sector:Manufacture of pharmaceuticals - C.21
- Outcome:Cleared
Documents
M.13.021 Merger AnnouncementPDF | 47 KBM.13.021 Merger Announcement PDF | 47 KB - Opens in new window
M.13.021 DeterminationPDF | 82 KBM.13.021 Determination PDF | 82 KB - Opens in new window
Timetable
Parties Involved
Aspen Pharmacare Holdings Limited
Aspen is a globally competitive producer of high quality affordable generic medicines and is involved in the development, registration, manufacture, import, marketing, selling and distribution of pharmaceutical products.
MSD NL 8 B.V.
MSD BV is comprised of the API manufacturing business which manufactures unprocessed APIs both for Merck and Co Incorporated and the market generally.
Contacts
